307 related articles for article (PubMed ID: 36334015)
21. Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
J Clin Gastroenterol; 2018 Aug; 52(7):e53-e62. PubMed ID: 28723856
[TBL] [Abstract][Full Text] [Related]
22. Significance of Serum Leucine-rich Alpha-2 Glycoprotein as a Diagnostic Marker in Pediatric Inflammatory Bowel Disease.
Yoshimura S; Okata Y; Ooi M; Horinouchi T; Iwabuchi S; Kameoka Y; Watanabe A; Kondo A; Uemura K; Tomioka Y; Samejima Y; Nakai Y; Nozu K; Kodama Y; Bitoh Y
Kobe J Med Sci; 2024 Jan; 69(4):E122-E128. PubMed ID: 38379274
[TBL] [Abstract][Full Text] [Related]
23. Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis.
Karashima R; Sagami S; Yamana Y; Maeda M; Hojo A; Miyatani Y; Nakano M; Matsuda T; Hibi T; Kobayashi T
Intest Res; 2024 Jun; ():. PubMed ID: 38835140
[TBL] [Abstract][Full Text] [Related]
24. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
26. High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
Bodelier AG; Jonkers D; van den Heuvel T; de Boer E; Hameeteman W; Masclee AA; Pierik MJ
Dig Dis Sci; 2017 Feb; 62(2):465-472. PubMed ID: 27933473
[TBL] [Abstract][Full Text] [Related]
27. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
[TBL] [Abstract][Full Text] [Related]
28. Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study.
Negm M; Bahaa A; Farrag A; Lithy RM; Badary HA; Essam M; Kamel S; Sakr M; Abd El Aaty W; Shamkh M; Basiony A; Dawoud I; Shehab H
BMC Gastroenterol; 2022 Apr; 22(1):203. PubMed ID: 35462542
[TBL] [Abstract][Full Text] [Related]
29. Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.
Pinto-Lopes P; Melo F; Afonso J; Pinto-Lopes R; Rocha C; Melo D; Macedo G; Dias CC; Carneiro F; Magro F;
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00320. PubMed ID: 33704099
[TBL] [Abstract][Full Text] [Related]
30. Altered fecal bile acid composition in active ulcerative colitis.
Sommersberger S; Gunawan S; Elger T; Fererberger T; Loibl J; Huss M; Kandulski A; Krautbauer S; Müller M; Liebisch G; Buechler C; Tews HC
Lipids Health Dis; 2023 Nov; 22(1):199. PubMed ID: 37980492
[TBL] [Abstract][Full Text] [Related]
31. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
32. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
33. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
Serada S; Fujimoto M; Terabe F; Iijima H; Shinzaki S; Matsuzaki S; Ohkawara T; Nezu R; Nakajima S; Kobayashi T; Plevy SE; Takehara T; Naka T
Inflamm Bowel Dis; 2012 Nov; 18(11):2169-79. PubMed ID: 22374925
[TBL] [Abstract][Full Text] [Related]
34. GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.
Dierckx T; Verstockt B; Vermeire S; van Weyenbergh J
J Crohns Colitis; 2019 Mar; 13(3):389-394. PubMed ID: 30312386
[TBL] [Abstract][Full Text] [Related]
35. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
[TBL] [Abstract][Full Text] [Related]
36. Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients.
Bodelier AG; Pierik MJ; van den Heuvel T; Bovee-Oudenhoven IM; de Boer E; Hameeteman W; Masclee AA; Jonkers D
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):902-9. PubMed ID: 24915490
[TBL] [Abstract][Full Text] [Related]
37. Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopy.
Kawamoto A; Takenaka K; Hibiya S; Kitazume Y; Shimizu H; Fujii T; Saito E; Ohtsuka K; Okamoto R
Intest Res; 2024 Jan; 22(1):65-74. PubMed ID: 37939721
[TBL] [Abstract][Full Text] [Related]
38. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.
Schaffer T; Schoepfer AM; Seibold F;
J Crohns Colitis; 2014 Sep; 8(9):1125-32. PubMed ID: 24636141
[TBL] [Abstract][Full Text] [Related]
39. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
40. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
van Rheenen PF
Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]